PLATINUM Small Vessel Trial

Platinum Chromium Everolimus-Eluting Clinical Experience

Study Objective: Evaluate the safety and effectiveness of the Promus PtCr EES Stent System1 for the treatment of de novo lesions ≤ 28 mm in length; ≥ 2.25mm to ≤ 2.50 mm in diameter
Study Design: Prospective, Single-arm, Multicenter

0% ARC ST (Def/Prob) and 0% TV-MI

PLATINUM Small Vessel Trial

2-Year Results2

1.5% ARC ST (Def/Prob) and 1.5% TV-MI

SPIRIT Small Vessel Registry

2-Year Results in Perspective3,4

1.4% ARC ST (Def/Prob) and 1.4% TV-MI


2-Year Results in Perspective4,5

 Promus PREMIER™

Submit Questions

 Promus PREMIER™

Product Updates